| 國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Sollano, J.; De Man, R. A.; Mutimer, D.; Gish, R. G.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-03 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Chang, Ting-Tsung; Chao, You-Chen; Sollano, Jose; Han, Kwang-Hyub; Lai, Ching-Lung; Lao-Tan, Judy; Akbar, Nurul; Zhu, Jin; Cross, Anne; Brett-Smith, Helena; Neo, Boon-Leong |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
|
Akarca, U.; Hatzis, G.; Kitis, G.; Shouval, D.; Lai, C.; Cheinquer, H.; Chang, Ting-Tsung; Zink, R.; Zhu, J.; Brett-Smith, H. |
| 國立成功大學 |
2012-09 |
Entecavir efficacy and safety in patients >= 50 years of age
|
Sievert, W.; Wedemeyer, H.; Gish, R.; Nguyen, T.; Lai, C. L.; Llamoso, C.; Chang, T. T. |
| 國立成功大學 |
2006-10-27 |
ENTECAVIR MAINTAINED VIROLOGIC SUPPRESSION THROUGH 3 YEARS OF TREATMENT IN ANTIVIRALNAı‥VE HBEAG PATIENTS (ETV 022/901)
|
Chang, Ting-Tsung; Chao, You-Chen; Sabahattin Kaymakoglu; Hugo Cheinquer; Mario Pessoa; Robert Gish; Fred Poordad; Yang, Joanna; Helena Brett-Smith; Robert Hindes |
| 國立臺灣大學 |
2013 |
ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
|
Liu, C. -J.; Wang, C. -C.; Yang, S. -S.; Su, C. -W.; Liao, L. -Y.; Lee, T. -H.; Chuang, W. -L.; Chen, C. -L.; Chien, R. -N.; Peng, C. -Y.; Lee, C. -M.; Lee, Y. -F.; Kao, J. -H.; Chen, P. -J.; Chen, D. -S.; 劉俊人 |
| 臺大學術典藏 |
2022-01-24T09:30:51Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng P.-N.; CHUN-JEN LIU; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-02-14T23:55:40Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng, Pin Nan; CHUN-JEN LIU; Chen, Chi Yi; Tseng, Kuo Chih; Lo, Ching Chu; Peng, Cheng Yuan; Lin, Chih Lin; Chiu, Hung Chih; Chiu, Yen Cheng; PEI-JER CHEN |
| 國立成功大學 |
2022-12 |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng;Pin-Nan;Liu;Chun-Jen;Chen;Chi-Yi;Tseng;Kuo-Chih;Lo;Ching-Chu;Peng;Cheng-Yuan;Lin;Chih-Lin;Chiu;Hung-Chih;Chiu;Yen-Cheng;Chen;Pei-Jer |
| 國立成功大學 |
2007-11 |
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
|
Gish, Robert G.; Lok, Anna S.; Chang, Ting-Tsung; De Man, Robert A.; Gadano, Adrian; Sollano, Jose; Han, Kwang-Hyub; Chao, You-Chen; Lee, Shou-Dong; Harris, Melissa; Yang, Joanna; Colonno, Richard; Brett-Smith, Helena |
| 國立成功大學 |
2010-01 |
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
|
Chang, Ting-Tsung; Lai, Ching-Lung; Yoon, Seung-Kew; Lee, Samuel S.; Henrique Sergio M. Coelho; Flair Jose Carrilho; Fred Poordad; Waldemar Halota; Yves Horsmans; Tsai , Naoky; Zhang, Hui; Daniel J. Tenney; Ricardo Tamez |
| 國立臺灣大學 |
2016 |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
Chang, Kai-Chi; Wu, Jia-Feng; Hsu, Hong-Yuan; Chen, Huey-Ling; Ni, Yen-Hsuan; Chang, Mei-Hwei; 倪衍玄; 張美惠; 許宏遠; 吳嘉?; 張凱琪; 陳慧玲 |
| 臺大學術典藏 |
2019-12-25T04:04:07Z |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
Chang K.-C.; Wu J.-F.; HONG-YUAN HSU; Chen H.-L.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-03-10T03:29:54Z |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
HUEY-LING CHEN; Ni Y.-H.; Chang M.-H.; Hsu H.-Y.; Wu J.-F.; Chang K.-C. |
| 臺大學術典藏 |
2020-12-21T01:08:31Z |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
Chang M.-H.; Ni Y.-H.; Chen H.-L.; Hsu H.-Y.; JIA-FENG WU; Chang K.-C. |
| 臺大學術典藏 |
2016 |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
Chang M.-H.; Chang K.-C.; Wu J.-F.; Hsu H.-Y.; Chen H.-L.; YEN-HSUAN NI |
| 臺大學術典藏 |
2021-01-04T07:32:20Z |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
Chang K.-C.; Wu J.-F.; Hsu H.-Y.; Chen H.-L.; Ni Y.-H.; MEI-HWEI CHANG |
| 臺大學術典藏 |
2021-07-22T08:13:28Z |
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
|
KAI-CHI CHANG; Wu J.-F.; Hsu H.-Y.; Chen H.-L.; Ni Y.-H.; Chang M.-H. |
| 國立成功大學 |
2006-03-09 |
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
|
Lai, Ching-Lung; Shouval, Daniel; Lok, Anna S.; Chang, Ting-Tsung; Cheinquer, Hugo; Goodman, Zachary; DeHertogh, Deborah; Wilber, Richard; Zink, Richard C.; Cross, Anne; Colonno, Richard; Fernandes, Lori |
| 義守大學 |
2011-12 |
Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Daw-Shyong Perng;Cheng-Hao Tseng;Gin-Ho Lo;Chih-Min Tai;Chih-Wen Lin;Chia-Chang Hsu;Chuan-Yuan Hsu;Shih-Che Huang;Jaw-Town Lin |
| 國立臺灣大學 |
2012 |
Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation
|
Hsu, Yao-Chun; Mo, Lein-Ray; Chang, Chi-Yang; Perng, Daw-Shyong; Tseng, Cheng-Hao; Lo, Gin-Ho; Tai, Chih-Min; Lin, Chih-Wen; Hsu, Chia-Chang; Hsu, Chuan-Yuan; Huang, Shih-Che; Lin, Jaw-Town; 林肇堂 |
| 國立成功大學 |
2008-10 |
Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients
|
Cheng, Pin-Nan; Chang, Ting-Tsung |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
|
Keating, G.M.; Buti, M.; Gadano, A. ;Kao, J.-H. ;Lee, C.-M.; Peng, C.-Y.; Schiff, E.R.; Tanwandee, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:12Z |
Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
|
Keating G.M.; Buti M.; Gadano A.; JIA-HORNG KAO; Lee C.-M.; Peng C.-Y.; Schiff E.R.; Tanwandee T. |
